CASTELLANI, CARLOTTA
 Distribuzione geografica
Continente #
NA - Nord America 158
AS - Asia 154
EU - Europa 92
SA - Sud America 18
AF - Africa 3
OC - Oceania 1
Totale 426
Nazione #
US - Stati Uniti d'America 153
SG - Singapore 39
CN - Cina 30
BD - Bangladesh 26
HK - Hong Kong 25
IT - Italia 22
BR - Brasile 18
VN - Vietnam 18
DE - Germania 13
RU - Federazione Russa 11
GB - Regno Unito 10
FI - Finlandia 9
FR - Francia 6
SE - Svezia 6
IN - India 5
CA - Canada 4
ID - Indonesia 4
IE - Irlanda 4
KR - Corea 3
NL - Olanda 3
CI - Costa d'Avorio 2
ES - Italia 2
TR - Turchia 2
BE - Belgio 1
CH - Svizzera 1
GT - Guatemala 1
IQ - Iraq 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 426
Città #
Ashburn 22
Hong Kong 22
Singapore 19
Fairfield 13
Council Bluffs 11
San Jose 10
Woodbridge 10
Los Angeles 9
Helsinki 8
Seattle 8
Chandler 7
Southend 7
Ann Arbor 6
Cambridge 6
Hefei 6
Ho Chi Minh City 6
Hanoi 5
New York 5
Santa Clara 5
São Paulo 4
Wilmington 4
Bengaluru 3
Buffalo 3
Houston 3
Jakarta 3
Lauterbourg 3
Milan 3
Moscow 3
Rome 3
Tianjin 3
Abidjan 2
Berlin 2
Chicago 2
Dallas 2
Dhaka 2
Dublin 2
Falkenstein 2
Guangzhou 2
Hangzhou 2
Limerick 2
Naples 2
Princeton 2
San Diego 2
Seoul 2
Toronto 2
Atlanta 1
Baghdad 1
Bangkok 1
Beijing 1
Betim 1
Birmingham 1
Boardman 1
Boston 1
Bühl 1
Camaçari 1
Can Tho 1
Cape Town 1
Catania 1
Chambéry 1
Charlemont 1
Charlotte 1
Cidade Ocidental 1
Columbus 1
Comox 1
Contagem 1
Da Nang 1
Des Moines 1
Dunedin 1
Düsseldorf 1
Erlangen 1
Fall River 1
Gaston 1
Goiânia 1
Governador Valadares 1
Hackney 1
Haiphong 1
Helena 1
Hengyang 1
Hüttenberg 1
Indramayu 1
Istanbul 1
Kaspiysk 1
Kayseri 1
Krakow 1
Lappeenranta 1
Louisville 1
Madrid 1
Maracanaú 1
Mauá 1
Mercato Cilento 1
Mixco 1
Nam-gu 1
New Kensington 1
Nha Trang 1
Nuremberg 1
Orem 1
Oslo 1
Ottawa 1
Perm 1
Phủ Từ Sơn 1
Totale 305
Nome #
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis 200
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life 127
Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials 112
Totale 439
Categoria #
all - tutte 1.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/202212 1 0 1 0 1 2 0 1 3 1 1 1
2022/202320 3 5 1 2 3 4 0 0 0 1 1 0
2023/20248 0 0 2 0 0 0 0 0 0 1 0 5
2024/202562 4 2 0 2 5 4 6 7 11 7 5 9
2025/2026260 10 8 17 28 39 12 38 15 25 11 13 44
Totale 439